Argan vs Matrix Service
AGX and MTRX side by side, both in industrials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGX and MTRX compare
Argan is the larger company, worth 17 times as much as Matrix Service ($4.1B against $243M).
Argan grew revenue faster over the last twelve months (29.0% versus 13.6% for Matrix Service).
Argan keeps more of each dollar of sales as profit, with a net margin of 15.1% compared with −0.30% at Matrix Service.
Argan pays a dividend yielding 0.51%; Matrix Service does not pay one.
Argan scores higher on the StockData Score (21 against 10 for Matrix Service), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGX | MTRX |
|---|---|---|
| Size and price | ||
| Market cap | $4.1B | $243M |
| Share price | $293.25 | $8.58 |
| Change, 1 year | −16.6% | −27.5% |
| Change, 5 years | 625% | −8.3% |
| Beta (5Y) | 0.71 | 0.10 |
| Employees | 1,409 | 2,370 |
| StockData Score | ||
| Total score | 21 (better) | 10 |
| Valuation score | 1 | 3 (better) |
| Growth score | 5 (better) | 2 |
| Performance score | 6 (better) | 2 |
| Health score | 6 (better) | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 23.2× | – |
| P/S | 3.5× | 0.3× (better) |
| P/B | 8.1× | – |
| EV/EBITDA | 19.5× | – |
| P/FCF | 7.5× (better) | 170× |
| PEG | 0.38 | – |
| FCF yield | 13.3% (better) | 0.59% |
| Fair value | $255.31 | $21.17 |
| Margin of safety | −14.9% | 59.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 29.0% (better) | 13.6% |
| Revenue growth, 5Y average | 19.2% (better) | 5.3% |
| Net income growth (TTM) | 53.0% | – |
| EPS growth (TTM) | 51.9% | – |
| EPS growth, 5Y average | 45.2% | – |
| Profitability | ||
| Gross margin | 20.9% (better) | 7.3% |
| Operating margin | 15.4% (better) | −1.1% |
| Net margin | 15.1% (better) | −0.30% |
| FCF margin | 45.9% (better) | 0.16% |
| Return on equity | 39.8% | – |
| Return on invested capital | 396% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −22.0× |
| Current ratio | 1.50 (better) | 0.98 |
| Altman Z-score | 4.91 (better) | 1.70 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 0.51% | – |
| Payout ratio | 15.6% | – |
| Years of dividend growth | 4 | – |
| Dividend growth, 5Y average | 47.6% | – |
| Buyback yield | 0.30% | – |
| Shareholder yield | 0.81% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 99.4% | 91.7% |
| Held by insiders | 9.3% | 5.5% |
| Insider net buying, 12 months | −$147M | −$2.3M (better) |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 7.0% | 7.4% |
Go deeper
- AGX stock overview
- AGX income statement
- AGX valuation and score
- MTRX stock overview
- MTRX income statement
- MTRX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.